Abstract
Myelofibrosis (MF) is characterized by increased numbers of morphologically abnormal megakaryocytes (Mks). Single-cell RNA sequencing of >120,000 hematopoietic stem and progenitor cells demonstrated Mk-biased hematopoiesis across clinical and molecular MF subgroups. Mk progenitors were heterogeneous, with distinct expression of inflammatory mediators. Aberrant surface G6B expression on MF stem and progenitors could allow selective immunotherapeutic targeting of the MF clone.
Original language | English (US) |
---|---|
Pages (from-to) | 477-492.e8 |
Journal | Molecular cell |
Volume | 78 |
Issue number | 3 |
DOIs | |
State | Published - May 7 2020 |
Externally published | Yes |
Keywords
- G6B
- TARGET-seq
- bone marrow
- fibrosis
- immunotherapy
- megakaryopoiesis
- myeloproliferative neoplasm
- platelets
- single-cell multi-omics
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology